Logotype for Palisade Bio Inc

Palisade Bio (PALI) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Palisade Bio Inc

Proxy Filing summary

2 Dec, 2025

Executive summary

  • The annual meeting will be held virtually on October 17, 2025, with voting available online, by phone, or by mail.

  • Three main proposals are up for vote: election of three directors, ratification of the independent auditor, and approval of a reverse stock split.

  • Only stockholders of record as of September 12, 2025, are eligible to vote.

Voting matters and shareholder proposals

  • Proposal 1: Elect three directors (J.D. Finley, Donald Williams, Emil Chuang) for a one-year term expiring at the 2026 annual meeting.

  • Proposal 2: Ratify Baker Tilly US, LLP as the independent registered public accounting firm for 2025.

  • Proposal 3: Approve a reverse stock split at a ratio between 1-for-5 and 1-for-50, at the Board's discretion, to be effected by December 31, 2025.

  • No other matters are expected to be presented for a vote.

Board of directors and corporate governance

  • The Board consists of four members, three of whom are independent as per Nasdaq rules.

  • The classified board structure was removed in February 2024; all directors are now elected annually.

  • The Board has Audit, Compensation, and Governance and Nominating Committees, all with independent members.

  • The Board Chair is independent, and the Board meets regularly, with all directors attending at least 75% of meetings in 2024.

  • A Code of Business Conduct and Ethics and an insider trading policy are in place.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more